Carbogen and nicotinamide as radiosensitizers in a murine mammary carcinoma using conventional and accelerated radiotherapy
- 1 January 1996
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 34 (2), 357-365
- https://doi.org/10.1016/0360-3016(95)02087-x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Influence of combined use of nicotinamide and carbogen on rat spinal cord radiation toleranceRadiotherapy and Oncology, 1994
- Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing timeBritish Journal of Cancer, 1993
- Nicotinamide pharmacokinetics in humans and mice: a comparative assessment and the implications for radiotherapyRadiotherapy and Oncology, 1993
- Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivoBritish Journal of Cancer, 1991
- Hyperfractionated compared with conventional radiotherapy in oropharyngeal carcinoma: an EORTC randomized trialEuropean Journal of Cancer and Clinical Oncology, 1990
- How worthwhile are short schedules in radiotherapy?: A series of exploratory calculationsRadiotherapy and Oncology, 1990
- Mechanism of action of the selective tumor radiosensitizer nicotinamideInternational Journal of Radiation Oncology*Biology*Physics, 1988
- Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1988
- Carcinoma of the cervix—anaemia, radiotherapy and hyperbaric oxygenThe British Journal of Radiology, 1983
- Is tumour radiosensitization by misonidazole a general phenomenon?British Journal of Cancer, 1980